{"id":54654,"date":"2023-03-08T23:04:39","date_gmt":"2023-03-08T22:04:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/"},"modified":"2023-03-08T23:04:39","modified_gmt":"2023-03-08T22:04:39","slug":"quanterix-to-participate-in-barclays-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/","title":{"rendered":"Quanterix to Participate in Barclays Global Healthcare Conference"},"content":{"rendered":"<div>\n<p>BILLERICA, Mass.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.quanterix.com%2F&amp;esheet=53357975&amp;newsitemid=20230308005196&amp;lan=en-US&amp;anchor=Quanterix+Corporation&amp;index=1&amp;md5=f576a2022685e2757bf0fb9ebded0bb7\" rel=\"nofollow noopener\" shape=\"rect\">Quanterix Corporation<\/a> (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:35 p.m., EDT. In addition, the company will also host in-person one-on-one meetings with institutional investors on March 15.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230308005196\/en\/778515\/4\/Quanterix_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230308005196\/en\/778515\/21\/Quanterix_Logo.jpg\"><\/a><\/p>\n<p>\nFor those interested in tuning in to the presentation virtually, please register here: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fevent.webcasts.com%2Fstarthere.jsp%3Fei%3D1599088%26tp_key%3Dffe17ea0e1%26tp_special%3D8&amp;esheet=53357975&amp;newsitemid=20230308005196&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevent.webcasts.com%2Fstarthere.jsp%3Fei%3D1599088%26amp%3Btp_key%3Dffe17ea0e1%26amp%3Btp_special%3D8&amp;index=2&amp;md5=dbbb76187d18abe441bd794df64b4e65\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/event.webcasts.com\/starthere.jsp?ei=1599088&amp;tp_key=ffe17ea0e1&amp;tp_special=8<\/a>. Replays of the presentation will be available for a limited period following the conference. The webcast and presentation will also be made available through the Investor Relations section of Quanterix\u2019s website.\n<\/p>\n<p>\nTo learn more about Quanterix, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.quanterix.com%2Fcompany%2F&amp;esheet=53357975&amp;newsitemid=20230308005196&amp;lan=en-US&amp;anchor=www.quanterix.com%2Fabout&amp;index=3&amp;md5=25bd0bbb7a0d5c04fa54ae12035e69e8\" rel=\"nofollow noopener\" shape=\"rect\">www.quanterix.com\/about<\/a>. To learn more about Quanterix\u2019s Simoa<sup>\u00ae<\/sup> technology, visit: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.quanterix.com%2Ftechnology&amp;esheet=53357975&amp;newsitemid=20230308005196&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.quanterix.com%2Ftechnology&amp;index=4&amp;md5=2723bdf6e8f500b8d92624896af1c710\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.quanterix.com\/technology<\/a>.\n<\/p>\n<p>\n<b>About Quanterix<\/b>\n<\/p>\n<p>\nFrom discovery to diagnostics, Quanterix\u2019s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company\u2019s Simoa<sup>\u00ae <\/sup>technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Limit of Quantification (LoQ) of conventional analog methods. Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 2,000 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.quanterix.com&amp;esheet=53357975&amp;newsitemid=20230308005196&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.quanterix.com&amp;index=5&amp;md5=d7730e06cd5cb077ba8630be64cef1c7\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.quanterix.com<\/a> or follow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FQuanterixSimoa&amp;esheet=53357975&amp;newsitemid=20230308005196&amp;lan=en-US&amp;anchor=Twitter&amp;index=6&amp;md5=2f8a5737f0ce10f2562298b548e6c1cb\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fquanterix%2F&amp;esheet=53357975&amp;newsitemid=20230308005196&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=7&amp;md5=ce69ff370ad782e8888ee4826527dd6f\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Contact:<\/b><br \/>PAN Communications<br \/>\n<br \/>Maya Nimnicht<br \/>\n<br \/>510-334-6273<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;q&#x75;&#x61;&#110;&#x74;e&#x72;&#x69;&#120;&#x40;p&#x61;&#x6e;&#99;&#x6f;m&#x6d;&#x2e;&#99;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#113;&#x75;&#97;&#x6e;&#116;&#x65;&#114;&#x69;&#120;&#x40;&#112;&#x61;n&#x63;o&#x6d;m&#x2e;c&#x6f;m<\/a><\/p>\n<p><b>Investor Relations Contact:<\/b><br \/>Amy Achorn<br \/>\n<br \/>(978) 488-1854<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x69;r&#x40;q&#x75;a&#x6e;t&#101;&#x72;&#105;&#x78;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#105;&#x72;&#x40;&#113;&#x75;&#x61;&#110;&#x74;&#x65;&#114;&#x69;&#x78;&#46;&#x63;&#x6f;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BILLERICA, Mass.&#8211;(BUSINESS WIRE)&#8211;Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:35 p.m., EDT. In addition, the company will also host in-person one-on-one meetings with institutional investors on March 15. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54654","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Quanterix to Participate in Barclays Global Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quanterix to Participate in Barclays Global Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BILLERICA, Mass.&#8211;(BUSINESS WIRE)&#8211;Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:35 p.m., EDT. In addition, the company will also host in-person one-on-one meetings with institutional investors on March 15. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-08T22:04:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230308005196\/en\/778515\/21\/Quanterix_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Quanterix to Participate in Barclays Global Healthcare Conference\",\"datePublished\":\"2023-03-08T22:04:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/\"},\"wordCount\":301,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230308005196\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/\",\"name\":\"Quanterix to Participate in Barclays Global Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230308005196\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\",\"datePublished\":\"2023-03-08T22:04:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230308005196\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230308005196\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-to-participate-in-barclays-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quanterix to Participate in Barclays Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quanterix to Participate in Barclays Global Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Quanterix to Participate in Barclays Global Healthcare Conference - Pharma Trend","og_description":"BILLERICA, Mass.&#8211;(BUSINESS WIRE)&#8211;Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:35 p.m., EDT. In addition, the company will also host in-person one-on-one meetings with institutional investors on March 15. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-08T22:04:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230308005196\/en\/778515\/21\/Quanterix_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Quanterix to Participate in Barclays Global Healthcare Conference","datePublished":"2023-03-08T22:04:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/"},"wordCount":301,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230308005196\/en\/778515\/21\/Quanterix_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/","name":"Quanterix to Participate in Barclays Global Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230308005196\/en\/778515\/21\/Quanterix_Logo.jpg","datePublished":"2023-03-08T22:04:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230308005196\/en\/778515\/21\/Quanterix_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230308005196\/en\/778515\/21\/Quanterix_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/quanterix-to-participate-in-barclays-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Quanterix to Participate in Barclays Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54654"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54654\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}